| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/02/2008 | US7419811 Mutant kinase; anticancer agents; supplying to leukemia blastocytes; antibody which detects cell surface antigen; antiproliferative agent |
| 09/02/2008 | US7419808 Methods and compositions for the production of adenoviral vectors |
| 09/02/2008 | US7419807 High molecular weight; isolated nucleic acid; use in detecting antibodies in test sample; diagnostic kit |
| 09/02/2008 | US7419806 Immunogenic Mycoplasma hyopneumoniae polypeptides |
| 09/02/2008 | US7419799 Medical diagnosis; gene expression; genetic engineering; cell proliferation |
| 09/02/2008 | US7419794 Antibodies specific for CYP1B1 |
| 09/02/2008 | US7419792 Detecting binding of said antigen in tissue sample; treating cells to aid in differentiation, treatment and diagnostic imaging |
| 09/02/2008 | US7419790 Sodium-independent transporter carrying acidic amino acid and its gene |
| 09/02/2008 | US7419789 Method of inhibiting binding of Dengue virus to a human cell with DC-SIGN blockers |
| 09/02/2008 | US7419781 Of given sequence, with post-translational modifications; use in drugs for treating bacterial infections |
| 09/02/2008 | US7419675 Method for treating peritoneal adhesions |
| 09/02/2008 | US7419674 Alpha virus-based cytomegalovirus vaccines |
| 09/02/2008 | US7419672 Genes and proteins, and their use |
| 09/02/2008 | US7419671 For therapy and prophylaxis of Porphyromonas gingivalis infection |
| 09/02/2008 | US7419670 Method of treating arthritis with SERP-1 and an immunosuppressant |
| 09/02/2008 | US7419669 Peptide epitopes common to antigens of the same multigene family |
| 09/02/2008 | US7419668 Protein antigen isolated from Sarcocystis neurona; passive immunity |
| 09/02/2008 | US7419667 Drug for cancer therapy |
| 09/02/2008 | US7419666 Treatment of ocular disorders |
| 09/02/2008 | US7419665 Monoclonal antibodies for detection of urinary trypsin inhibitors |
| 09/02/2008 | US7419664 Expression or activity of soluble CLCA1(chloride channel A1) is up-regulated, by administering inhibitors of soluble CLCA1 |
| 09/02/2008 | US7419663 by administering a STIgMA polypeptide or its agonist; autoimmune, respiratory, kidney, skin, cardiovascular disorders, hepatitis |
| 09/02/2008 | US7419662 Methods of making chemokine alpha 3 antibodies |
| 09/02/2008 | US7419660 Isolating nucleic acid from malignant cells, inserting into expression vector, transformation; light regions differ by one idiotope |
| 09/02/2008 | US7419657 Reducing antibody-mediated lipid peroxidation activity in vascular systems; idiotypic antibodies; chlamydia pneumoniae vaccines |
| 09/02/2008 | CA2397773C Universal procedure for refolding recombinant proteins |
| 09/02/2008 | CA2389333C Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 09/02/2008 | CA2372053C Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 09/02/2008 | CA2325818C Topical immunostimulation to induce langerhans cell migration |
| 09/02/2008 | CA2303478C Group a streptococcal vaccines |
| 09/02/2008 | CA2301067C Rapid cryobaric sterilization and vaccine preparation |
| 09/02/2008 | CA2246430C Protein tyrosine phosphatases of hematopoietic cells |
| 09/02/2008 | CA2175577C Receptor on the surface of activated t-cells: acts-4 |
| 09/02/2008 | CA2146973C Uses of tgf-.beta. receptor fragment as a therapeutic agent |
| 09/02/2008 | CA2144307C Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
| 08/28/2008 | WO2008103953A2 Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized ldl receptor-1 (lox-1) |
| 08/28/2008 | WO2008103947A2 Activation of human antigen-presenting cells through clec-6 |
| 08/28/2008 | WO2008103920A2 Targeted protein cages |
| 08/28/2008 | WO2008103905A2 Antibodies that specifically bind irta and methods of use |
| 08/28/2008 | WO2008103819A2 Chimeric newcastle disease virus vlps |
| 08/28/2008 | WO2008103701A2 Ovr115 antibody compositions and methods of use |
| 08/28/2008 | WO2008103473A1 Engineered anti-il-23p19 antibodies |
| 08/28/2008 | WO2008103472A2 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 08/28/2008 | WO2008103432A1 Engineered anti-il-23p19 antibodies |
| 08/28/2008 | WO2008103431A2 Dnai - liposomes |
| 08/28/2008 | WO2008103428A2 Demannosylated hiv-1 gp120 envelope gylcoproteins, compositions thereof and methods relating thereto |
| 08/28/2008 | WO2008103409A2 Compositions of chloroquine coupled to antibodies and to other proteins with methods for their synthesis |
| 08/28/2008 | WO2008103397A1 Suppression of allergic inflammation by ascaris aba-1 antigen |
| 08/28/2008 | WO2008103392A2 Modulation of nkt cell activity with antigen-loaded cdid molecules |
| 08/28/2008 | WO2008103378A2 Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
| 08/28/2008 | WO2008102783A1 Hair regrowth promoter |
| 08/28/2008 | WO2008102368A1 Medicinal formulation containing a combination of hiv type i and hiv type ii |
| 08/28/2008 | WO2008102359A1 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins |
| 08/28/2008 | WO2008102340A2 Kits and methods for determining colon cleanliness |
| 08/28/2008 | WO2008102173A1 Compositions comprising polysaccharide conjugates and their use as vaccines |
| 08/28/2008 | WO2008101985A2 Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization |
| 08/28/2008 | WO2008101667A1 Method of purification of hydrophobic proteins |
| 08/28/2008 | WO2008101349A1 Recombinant viral vectors for prevention and protection against alphavirus infection |
| 08/28/2008 | WO2008084125A3 Method for the preparation of a scuticociliatosis vaccine for farmed marine fish |
| 08/28/2008 | WO2008084040A8 Use of mage a3-protein d fusion antigen in immunotherapy combined with surgery, chemotherapy or radiotherapy for the treatment of cancer |
| 08/28/2008 | WO2008073891A3 Salmonella vaccine in poultry |
| 08/28/2008 | WO2008070344A9 Compositions and methods for binding sphingosine-1-phosphate |
| 08/28/2008 | WO2008067071A3 Immune system programming through b7-dc |
| 08/28/2008 | WO2008060814A3 ANTI-IL-13Rα1 ANTIBODIES AND THEIR USES THEREOF |
| 08/28/2008 | WO2008060813A3 High affinity antibody antagonists of interleukin-13 receptor alpha 1 |
| 08/28/2008 | WO2008059018A3 Vaccine for vaccinating felines and canines against influenza virus |
| 08/28/2008 | WO2008010980A3 Tat-049 and methods of assessing and treating cancer |
| 08/28/2008 | WO2007150077A8 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 08/28/2008 | WO2007127506A8 Anti-ephrinb2 antibodies and methods using same |
| 08/28/2008 | WO2007113223A3 Immunogenic composition |
| 08/28/2008 | WO2007084253A3 High affinity antibodies against hmgb1 and methods of use thereof |
| 08/28/2008 | WO2007084181A3 Bispecific single chain fv antibody molecules and methods of use thereof |
| 08/28/2008 | WO2007076391A9 Tgf-beta binding compositions |
| 08/28/2008 | WO2006113782A3 Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof |
| 08/28/2008 | US20080207550 Immunomodulatory polynucleotides and methods of using the same |
| 08/28/2008 | US20080207548 Immunogenic polynucleotides, expression vectors, antigen presenting host cells, diagnostic kits; cancer vaccines |
| 08/28/2008 | US20080207547 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080207526 Synthetic peptides and methods of use for autoimmune disease therapies |
| 08/28/2008 | US20080207517 SELECTIVE INHIBITION OF NF-kappaB ACTIVIATION BY PEPTIDES DESIGNED TO DISRUPT NEMO OLIGOMERIZATION |
| 08/28/2008 | US20080207511 Isolated polypeptide comprising amino acid sequence encoded by polynucleotide; physiologically acceptable carriers and immunostimulants |
| 08/28/2008 | US20080207486 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206736 Administering a therapeutically effective amount of a flavin N-oxide; exposing flavin N-oxide to an activator, such that activation of the flavin N- oxide results in damage to the DNA in cancer cells without damage to the DNA in normal cells |
| 08/28/2008 | US20080206319 Mucosal adjuvants elicit strong balanced or adjusted immune response of humoral, cellular components; prophylaxis or treatment of infectious diseases or cancer; non-toxic; employed with a wide variety of active ingredients to be assisted in conventional or novel vaccines |
| 08/28/2008 | US20080206318 Administering complex formed from a soluble tumor-associated antigen and an antibody or antigen binding fragment thereof that binds to a first epitope of the tumor-associated antigen, wherein the tumor-associated antigen is CA 125 for therapy of oncological disease |
| 08/28/2008 | US20080206308 comprising a biodegradable unsaturated polymer selecting from polypropylene fumarate and polycaprolactone fumarate and a curing agent to form a porous scaffold in an mold or in a body cavity; for tissue regeneration; drug delivery devices; biodegradable, biocompatible scaffolds for tissue engineering |
| 08/28/2008 | US20080206289 identifying a human subject as a candidate for prostate cancer examination by determining whether the human has developed an immune reaction to a prostate cancer antigen; drug screening |
| 08/28/2008 | US20080206288 Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines |
| 08/28/2008 | US20080206287 synergistic anticarcinogenic treatment including vaccine which has a tumor necrosis factor death domains |
| 08/28/2008 | US20080206286 Brain tumors; dendritic cells pulsed with antigens from isolated cancer stem cells provided a significant survival benefit |
| 08/28/2008 | US20080206285 muramyl dipeptide adjuvant; mixture of excreted-secreted antigens obtained by a process comprising growing promastigotes of Leishmania sp. in an MPm medium |
| 08/28/2008 | US20080206284 E. coli heat-labile enterotoxin that binds to GM1 ganglioside receptors; allergic rhinitis |
| 08/28/2008 | US20080206283 Vaccine Against Sars |
| 08/28/2008 | US20080206282 Chimeric lyssavirus nucleic acids and polypeptides |
| 08/28/2008 | US20080206281 Method For Producing Storage Stable Viruses and Immunogenic Compositions Thereof |
| 08/28/2008 | US20080206280 nontarget antigen to sensitize a patient's CD8+ T cells followed with administration of a vaccine comprising a target antigen (such as a tumor-associated antigen or a pathogen-associated antigen); cancer and autoimmune diseases |
| 08/28/2008 | US20080206279 Human cells comprising sequence encoding early region-1 (E1) gene product of an adenovirus; cultured in suspension to very high densities under serum-free conditions |
| 08/28/2008 | US20080206278 Vaccine |
| 08/28/2008 | US20080206277 Isolated Nucleic Acid Molecule Encoding a Neurotrophic Growth Factor |
| 08/28/2008 | US20080206276 Targeting Poly-Gamma-Glutamic Acid to Treat Staphylococcus Epidermidis and Related Infections |
| 08/28/2008 | US20080206271 Contains a binding ligand, a Pseudomonas exotoxin A translocation domain II, an antigenic moiety, and a carboxyl terminal moiety which binds to the endoplasmic reticulum of the target T-cells, B-cells, dendritic cells, monocytes, or macrophages; inoculation |